CCL20 and COVID-19: Likewise, higher levels of CCL2, CCL7, CCL20, and CXCL10 were associated with lower blood lymphocyte count and higher inflammatory markers (CRP and ferritin) (Supplementary file 1g), which are clinical markers of severe disease and poorer outcome in COVID-19 (Gupta et al., 2021).